{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T21:40:18Z","timestamp":1710279618967},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.clinthera.2009.03.015","type":"journal-article","created":{"date-parts":[[2009,4,23]],"date-time":"2009-04-23T08:28:42Z","timestamp":1240475322000},"page":"609-618","source":"Crossref","is-referenced-by-count":6,"title":["An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects"],"prefix":"10.1016","volume":"31","author":[{"given":"Bo-Hyung","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Ryul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung Soo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu-pyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jang-Hee","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Goo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Sang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.03.015_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00005344-198804000-00005","article-title":"Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles","volume":"11","author":"Hattori","year":"1988","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.clinthera.2009.03.015_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0002-9149(96)00401-8","article-title":"Conversion of recent-onset Atrial Fibrillation by a single oral dose of pilsicainide (Pilsicainide Suppression Trial on atrial fibrillation)","volume":"78","author":"Atarashi","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2009.03.015_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1067\/mcp.2000.104018","article-title":"Effect of cimetidine and probenecid on pilsicainide renal clearance in humans","volume":"67","author":"Shiga","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2009.03.015_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02066484","article-title":"Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: A comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165","volume":"1","author":"Hashimoto","year":"1985","journal-title":"Heart Vessels"},{"key":"10.1016\/j.clinthera.2009.03.015_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1527-3466.1993.tb00267.x","article-title":"Pilsicainide, a new class I antiarrhythmic drug","volume":"11","author":"Hashimoto","year":"1993","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.clinthera.2009.03.015_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0014-2999(00)00418-0","article-title":"QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide","volume":"400","author":"Miyamoto","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clinthera.2009.03.015_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF00265853","article-title":"Pharmacokinetics of SUN 1165, a new antiarrhythmic agent, in renal dysfunction","volume":"40","author":"Takabatake","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2009.03.015_bib8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-2125.2008.03267.x","article-title":"Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects","volume":"66","author":"Lim","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2009.03.015_bib9_1","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Ethnic factors in the acceptability of foreign clinical data E5(R1). Current Step 4 version, Feb 1998 [ICH Web site]."},{"key":"10.1016\/j.clinthera.2009.03.015_bib10_1","unstructured":"Question and Answers, Bridging Study. Korean Food and Drug Administration. Guideline, 2006 [KFDA Web site]."},{"key":"10.1016\/j.clinthera.2009.03.015_bib11","first-page":"661","article-title":"Phase I study of SUN 1165, a novel antiarrhythmic agent. No. 1: Single dose study [in Japanese]","volume":"5","author":"Nakashima","year":"1989","journal-title":"J Clin Ther Med"},{"key":"10.1016\/j.clinthera.2009.03.015_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2133\/dmpk.20.183","article-title":"Effect of protein binding of pilsicainide on the pharmacokinetics","volume":"20","author":"Fukumoto","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.clinthera.2009.03.015_bib13_1","unstructured":"World Medical Association. Declaration of Helsinki: Ethical principles for medical research involving human subjects. As amended by the 55th World Medical Assembly [WMA Web site]."},{"key":"10.1016\/j.clinthera.2009.03.015_bib14","series-title":"Harrison's Principles of Internal Medicine","first-page":"246","article-title":"Azotemia and urinary abnormalities","author":"Denker","year":"2005"},{"key":"10.1016\/j.clinthera.2009.03.015_bib15_1","unstructured":"World Health Organization. International classification of adult underweight, normal weight, overweight, and obesity according to BMI."},{"key":"10.1016\/j.clinthera.2009.03.015_bib16","first-page":"174","article-title":"Efficacy of pilsicainide, class IC antiarrhythmic agent, on ventricular premature contraction [in Japanese]","volume":"16","author":"Asano","year":"1995","journal-title":"Ther Res"},{"key":"10.1016\/j.clinthera.2009.03.015_bib17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3999\/jscpt.20.719","article-title":"Clinical evaluation of SUN 1165 in patients with ventricular premature contractions\u2014a multicenter, double-blind, dose-finding study [in Japanese]","volume":"20","author":"Niitani","year":"1989","journal-title":"Jpn J Clin Pharmacol Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809000903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809000903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T21:05:12Z","timestamp":1710277512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809000903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0149291809000903"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.03.015","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}